| WKN: | A0NFN3 |
| ISIN: | CH0038389992 |
| Land: | Schweiz |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die BB Biotech-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 26. Oktober 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 1999 | 5,88 | 13,90 | 136,39% |
| 2 | 2014 | 23,07 | 39,46 | 71,04% |
| 3 | 2000 | 13,90 | 23,30 | 67,63% |
| 4 | 2013 | 14,55 | 23,07 | 58,56% |
| 5 | 2012 | 10,13 | 14,55 | 43,63% |
| 6 | 2015 | 39,46 | 54,09 | 37,08% |
| 7 | 2019 | 51,90 | 61,75 | 18,98% |
| 8 | 2025 | 37,25 | 43,00 | 15,44% |
| 9 | 2005 | 8,96 | 10,28 | 14,73% |
| 10 | 2006 | 10,28 | 11,56 | 12,45% |
| 11 | 2004 | 7,98 | 8,96 | 12,28% |
| 12 | 1998 | 5,32 | 5,88 | 10,53% |
| 13 | 2020 | 61,75 | 68,20 | 10,45% |
| 14 | 2009 | 9,18 | 10,07 | 9,70% |
| 15 | 2021 | 68,20 | 74,05 | 8,58% |
| 16 | 2017 | 51,54 | 55,84 | 8,34% |
| 17 | 2003 | 7,55 | 7,98 | 5,70% |
| 18 | 2011 | 9,88 | 10,13 | 2,53% |
| 19 | 2010 | 10,07 | 9,88 | -1,89% |
| 20 | 2016 | 54,09 | 51,54 | -4,71% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 16,70 | 7,55 | -54,79% |
| 2 | 2001 | 23,30 | 16,70 | -28,33% |
| 3 | 2022 | 74,05 | 56,40 | -23,84% |
| 4 | 2023 | 56,40 | 45,70 | -18,97% |
| 5 | 2024 | 45,70 | 37,25 | -18,49% |
| 6 | 2007 | 11,56 | 10,24 | -11,42% |
| 7 | 2008 | 10,24 | 9,18 | -10,35% |
| 8 | 2018 | 55,84 | 51,90 | -7,06% |
| 9 | 2016 | 54,09 | 51,54 | -4,71% |
| 10 | 2010 | 10,07 | 9,88 | -1,89% |
| 11 | 2011 | 9,88 | 10,13 | 2,53% |
| 12 | 2003 | 7,55 | 7,98 | 5,70% |
| 13 | 2017 | 51,54 | 55,84 | 8,34% |
| 14 | 2021 | 68,20 | 74,05 | 8,58% |
| 15 | 2009 | 9,18 | 10,07 | 9,70% |
| 16 | 2020 | 61,75 | 68,20 | 10,45% |
| 17 | 1998 | 5,32 | 5,88 | 10,53% |
| 18 | 2004 | 7,98 | 8,96 | 12,28% |
| 19 | 2006 | 10,28 | 11,56 | 12,45% |
| 20 | 2005 | 8,96 | 10,28 | 14,73% |